Mood Changes on Spironolactone: Separate Acne Outcomes From Drug Effects

HealthRX.com

The label does not list depression; mood reports remain unproven

Print or save as PDF

Key numbers

  • 20.4%Headache reported by women on spironolactone in SAFA, versus placebo (12.0%)Source: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • 3.77 pointsAdjusted acne quality-of-life gain over placebo at week 24, favouring spironolactoneSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • 18.5%Investigator-rated acne treatment success at week 12 with spironolactone (placebo 5.6%)Source: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026
  • 50 mg dailyStarting spironolactone dose in the SAFA acne trial, before the later increaseSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 7, 2026

See the public record for Spironolactone

At a glance

  • Label nervous-system list / Lethargy, mental confusion, ataxia, dizziness, headache, drowsiness [1]
  • Label frequency / Not estimable; voluntary reports, causality not established [1]
  • Mood outcome in acne trials / None measured; SAFA used a 0 to 30 acne quality-of-life scale [2][3]
  • Headache in SAFA / 20.4% vs 12.0% with placebo [2]
  • Serious adverse reactions in SAFA / None reported [2]
  • Acne-QoL difference at week 24 / 3.77 points (95% CI 2.50 to 5.03) [2]
  • Approval status for acne / Off-label; labeled uses are heart failure, hypertension add-on, edema and hyperaldosteronism [1]
  • Lithium / Reduced renal clearance and increased toxicity risk; periodic level monitoring [1]

Does spironolactone cause depression or anxiety?

The Aldactone label's adverse reactions section lists lethargy, mental confusion, ataxia, dizziness, headache and drowsiness under nervous system and psychiatric reactions [1]. Depression and anxiety are not among the reactions that section names [1]. The section also says these reactions were reported voluntarily, from a population of uncertain size, so their frequency cannot be estimated reliably and a causal relationship to the drug cannot be established [1].

Spironolactone is not approved for acne. Its labeled indications are heart failure with reduced ejection fraction, add-on hypertension therapy, edema in cirrhosis or nephrotic syndrome, and primary hyperaldosteronism [1]. Acne in women is an off-label use supported by randomized evidence [2].

What people on Reddit report

Reddit accounts from people on spironolactone who noticed mood changes. Some tie the change to a dose change, a new contraceptive, or another medicine.

queenoftheprairie · PCOS

My mom has actually experienced this!!! It ended up being a sign that the dosage was not right for her. She does not take it for PMOS, but she was experiencing low sodium episodes while taking spiro which can absolutely affect your mood!

Describes a relative whose mood changes were traced to the dose and to low sodium while taking spironolactone.

Read the source discussion

ToLorien · PCOS

I started about 3 months ago give or take and I do feel more moody! But I also had the nexplenon (spelling?) inserted around the same time and I've never tried this version of BC so I couldn't tell what was the cause.

Notes more moodiness after starting, but cannot separate the drug from a contraceptive implant placed at the same time.

Read the source discussion

Questions worth asking

Choose the questions you want to keep

What the acne trial measured

SAFA was a pragmatic, double-blind, randomized trial in 410 women aged 18 or older with facial acne present for at least six months and judged to warrant oral antibiotics: 201 received spironolactone and 209 placebo, and participants continued their usual topical treatments. The dose was 50 mg daily to week 6, then 100 mg daily to week 24 [2].

The primary outcome was the Acne-Specific Quality of Life symptom subscale at week 12, a 0 to 30 scale on which higher scores mean better quality of life [3]. The scale is acne-specific; it is not a depression or anxiety measure, so SAFA cannot say whether spironolactone changes mood. The adjusted difference between groups was 1.27 points (95% CI 0.07 to 2.46) at week 12 and 3.77 points (95% CI 2.50 to 5.03) at week 24, both favouring spironolactone [2].

Investigator-assessed treatment success at week 12 was 18.5% with spironolactone versus 5.6% with placebo (adjusted odds ratio 5.18, 95% CI 2.18 to 12.28), and 81.9% versus 63.3% of participants rated their acne improved at week 24 [2]. Headache was reported by 20.4% of the spironolactone group and 12.0% of the placebo group; no serious adverse reactions occurred, and other adverse reactions were similar between groups [2].

Other label warnings

The label's warnings cover hyperkalemia, hypotension and worsening renal function, and electrolyte and metabolic abnormalities including hyponatremia, hypomagnesemia, hypocalcemia, hypochloremic alkalosis and hyperglycemia [1]. The label says to monitor serum potassium within one week of starting or titrating the dose and regularly thereafter, to monitor volume status and renal function periodically, and to monitor serum electrolytes, uric acid and blood glucose periodically [1].

Medicines that change the picture

The label states that spironolactone reduces the renal clearance of lithium, increasing the risk of lithium toxicity, and that lithium levels should be monitored periodically during co-administration [1].

The label also names several drugs that raise potassium and add hyperkalemia risk with spironolactone: ACE inhibitors, angiotensin receptor blockers, NSAIDs, heparin and low molecular weight heparin, and trimethoprim. It says to check serum potassium when ACE inhibitor or angiotensin receptor blocker therapy is altered, and it names potassium supplements and potassium-containing salt substitutes as raising hyperkalemia risk [1].

Check what you know

Think you have it? Try 5 quick questions and see what the article says.

1. According to the Aldactone label, is depression among the nervous system and psychiatric reactions?

Question 1 of 5

Score: 0 right, 0 of 5 answered

Frequently asked questions

Can spironolactone cause depression?
Depression is not among the reactions listed in the Aldactone label's nervous system and psychiatric section, which names lethargy, mental confusion, ataxia, dizziness, headache and drowsiness [1].
How common are headaches on spironolactone for acne?
In SAFA, headache was reported by 20.4% of women taking spironolactone and 12.0% of those on placebo; no serious adverse reactions were reported [2].
Is spironolactone with lithium a problem?
The label says spironolactone reduces lithium renal clearance and increases the risk of lithium toxicity, and it calls for periodic lithium level monitoring [1].
Does the dose matter for the nervous system reactions?
The label lists the nervous system reactions without a dose-related frequency [1]. SAFA used 50 mg daily for six weeks, then 100 mg daily to week 24 [2].
Does the label call for potassium checks?
Yes. The Aldactone label says to monitor serum potassium within one week of starting or titrating the dose and regularly thereafter [1]. A retrospective study of healthy young women taking spironolactone for acne found hyperkalemia as rare as in comparison women, and its authors concluded that routine monitoring had low usefulness in that group [4].

Reader questions

What people actually ask

Short answers drawn from the sources this article cites.

What does spironolactone do mentally?

The Aldactone label lists lethargy, mental confusion, ataxia, dizziness, headache and drowsiness under nervous system and psychiatric reactions, but depression and anxiety are not among them. These reactions were reported voluntarily, so how often they occur cannot be estimated reliably. Any mental effect beyond the listed reactions is not established.

Are mood swings associated with spironolactone?

No association with mood changes is established. The acne trial measured acne-specific quality of life, not depression or anxiety, so it cannot show whether spironolactone affects mood. The Aldactone label does not name depression or anxiety, and a causal relationship to its listed nervous system reactions cannot be established.

Can spironolactone help anxiety?

The SAFA acne trial measured acne-specific quality of life, not depression or anxiety, so it cannot show whether spironolactone affects anxiety. Anxiety is not among the nervous system and psychiatric reactions the Aldactone label lists.

References

Show all 5 referencesHide references
  1. U.S. National Library of Medicine, DailyMed. Aldactone (spironolactone) tablets, Pfizer prescribing information. Aldactone (spironolactone) tablets, Pfizer label
  2. Santer M, Lawrence M, Pyne S, Renz S, Stuart BL, Sach T, et al. Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCT. Health Technol Assess. 2024.
  3. Santer M, Lawrence M, Renz S, Eminton Z, Stuart B, Sach TH, et al. Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial. BMJ. 2023.
  4. Plovanich M, Weng QY, Mostaghimi A. Low Usefulness of Potassium Monitoring Among Healthy Young Women Taking Spironolactone for Acne. JAMA Dermatol. 2015.
  5. Reddit participants. Mood swings from Spironolactone? (r/PCOS). Accessed 2026-11-11.
Adjusted SAFA Acne-QoL symptom score differences and 95% confidence intervals; this is not a depression or anxiety incidence.
Adjusted SAFA Acne-QoL symptom score differences and 95% confidence intervals; this is not a depression or anxiety incidence. Image: HealthRX.com original evidence diagramView full-size diagram